Malcolm Roberts (Queensland, Pauline Hanson's One Nation Party) | Hansard source

I move:

That the following matter be referred to the Select Committee on COVID-19 for inquiry and report by 30 October 2022:

The provisional approval of COVID-19 vaccines, including Pfizer, AstraZeneca, Moderna and Novavax ("the vaccines") by the Australian Technical Advisory Group on Immunisation, noting the requirement in section 22D of the Therapeutic Goods Act 1989 for the Secretary of the Department of Health ("the Secretary") to ensure the quality, safety and efficacy of the vaccines were satisfactorily established for each cohort the vaccine is being approved, with particular reference to:

(a) was the decision by the Secretary to not obtain patient-level data from the clinical trials of the vaccines or to independently investigate the vaccines a breach of the legislation;

(b) the failure of the Australian Bureau of Statistics to ensure that statistical reporting of COVID-19 policy metrics including mortality by age/cause and live births were provided in a timely manner;

(c) the process by which the Therapeutic Goods Administration (TGA) assessed reports of vaccine harm and deaths, including failure to conduct autopsies of vaccine deaths as reported by physicians;

(d) the use by the TGA of an internal version of the Database of Adverse Event Notifications, including any variance between public and internal vaccine harm data;

(e) the potential for gene-based vaccine generated spike proteins to migrate into human cell nuclei to disrupt DNA repair mechanisms, and the ability of vaccine-derived RNA to be reverse transcribed into human genome;

(f) failure to follow-up on animal trials of the vaccines that indicated substantial reproductive damage in lab rats, and any further work that may have been done on ensuring these vaccines have no negative effect on fertility; and

(g) the suppression of alternative treatments and non-pharmaceutical health advice.